Select Page
New research provides more evidence that psilocybin, the active ingredient in magic mushrooms, can improve creative thinking, empathy, and subjective well-being. The findings appear in the Journal of Psychoactive Drugs. "In the last decade, there has been a renewed scientific interest in the utility of psychedelics. Increasing evidence suggests that psychedelics like psilocybin may have potential therapeutic value for disorders like anxiety, depression, and PTSD," said Natasha Mason (@NL_Mason), a PhD candidate at Maastricht University and the corresponding author of the study. "The focus of such investigations has been on psychedelics capacity to reduce symptoms of these disorders, thereby improving mood and well-being. However, of equal importance are the higher-order cognitive processes that may be enhanced, or that may play a role in symptom alleviation of the disorders." "Examples of processes that have been found to be decreased in these pathologies include creative, flexible...